For His Part, Arsenault Said The Decision To Turn The Day-to-day Management Of Organigram Over To An Executive Of Engel’s Calibre Has Been Planned For Some Time.

“Organigram is poised to become one of the world’s leading marijuana producers; it will be gratifying to be part of a leadership team that helps the company achieve its goals.” Engel is a native of Picton, ON and earned an Honours Bachelor of Science degree in Microbiology from the University of Guelph in 1987 and then studied marketing at Queen’s University. He has also attended York University’s Schulich School of Business. For his part, Arsenault said the decision to turn the day-to-day management of Organigram over to an executive of Engel’s calibre has been planned for some time. “It has been 3 years to the day since I joined Organigram and I’ve achieved most of my goals as company CEO and believe it’s time for me to pass the torch to a seasoned Executive with demonstrated leadership skills” he said. “I will stay active in the areas of Investor Relations Medical marijuana and Capital Markets and look forward to working with Greg as he leads us through our next phase of expansion” he concluded. Arsenault also wanted to acknowledge the leadership of Monique Imbeault, who was Chairwoman of the Board over the past year, and remains an important part of our Board of Directors moving forward. About Organigram Holdings Inc. Organigram Holdings Inc. is a TSX Venture Exchange listed company whose wholly owned subsidiary, Organigram Inc., is a licensed producer of medical marijuana in Canada. Organigram is focused on producing the highest quality, condition specific medical marijuana for patients in Canada.

To read more visit

Comments are closed.